W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

News

Position of the Transparency Council – Keytruda (pembrolizumab)

more...

Opinion of the Transparency Council – health policy programme “Support of infertility treatment with the method of in vitro fertilization for the inhabitants of the city of Tychy for 2022-2025”

more...

Recommendation of the President – Treatment of advanced colorectal cancer (ICD-10: C18–C20)

more...

Recommendation of the President – Treatment of patients with advanced colorectal cancer (ICD-10: C18-C20)

more...

The Meeting of the Tariffs Council No. 16/2022 of 14.06.2022

more...

AOTMiT Webinar – Increase in expenditure on neonatal care. New tariffs and settlement conditions

more...

Communication on the meeting of the Tariff Council on 30 June 2022

more...

The Meeting of the Transparency Council No. 27/2022 of 11.07.2022

more...

Communication – acquisition of data Bone marrow biopsy (specialist outpatient care)

more...

Communication on the meeting of the Tariff Council on 23 and 24 June 2022

more...

Communication on the meeting of the Tariff Council on 23 and 24 June 2022

more...

Opinion of the Transparency Council – health policy programme of Piaseczno Poviat in the scope of prostate cancer prevention

more...

Opinion of the Transparency Council – amendments to PL B.59 on melanoma of the skin or mucous membranes

more...

Opinion of the Transparency Council – health policy programme of the Municipality of Zgierz in the scope of prevention and correction of vision in children

more...

Opinion of the Transparency Council – prevention of tick-borne encephalitis

more...

Opinion of the Transparency Council – health policy programme for the residents of the Warmińsko-Mazurskie Voivodeship within the scope of support for diagnostics and treatment of infertility excluding the methods of medically assisted reproduction

more...

The Meeting of the Tariffs Council No. 15/2022 of 30.06.2022

more...

The Meeting of the Transparency Council No. 14/2022 of 04.07.2022

more...

Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of retinoblastoma or von Hippel-Lindau (VHL) disease” as a guaranteed health care service

more...

Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of colorectal cancer or endometrial cancer” as a guaranteed health care service

more...

Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of breast or ovarian cancer” as a guaranteed health care service

more...

Position of the Transparency Council – qualifying the health care service “Colorectal cancer screening programme” as a guaranteed health care service

more...

Recommendation of the President – on the legitimacy of qualifying the health care service “Care for families at high hereditary risk for retinoblastoma or von Hippel-Lindau disease (VHL)” – as a guaranteed outpatient specialised care service

more...

Recommendation of the President – on the legitimacy of qualifying the health care service “Care for families at high hereditary risk for colorectal cancer or endometrial cancer – as a guaranteed outpatient specialised care service

more...